JANUX THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.56 USD | -4.58% |
|
-22.94% | +365.26% |
| 05-08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
| 05-08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 64.78 | 64.78 | 64.78 |
| Spread/Res. | -22.94% | -22.94% | -22.94% |
| Spread/Supp. | +5.99% | +147.02% | +170.88% |
| Support | 47.10 | 20.21 | 18.43 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- JANX Stock
- Charts Janux Therapeutics, Inc.
